FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2253177453> ?p ?o ?g. }

• W2253177453 endingPage "2339" @default.
• W2253177453 startingPage "2333" @default.
• W2253177453 abstract "PURPOSE The Canadian multicenter trial for advanced non-small-cell lung cancer (NSCLC) reported survival benefit for chemotherapy when best supportive care was compared with vindesine-cisplatin (VP) and the combination of cyclophosphamide, doxorubicin, and cisplatin (CAP). We examined received drug delivery to document dose-intensity (DI) and total dose of drugs given to various groups in this patient population. PATIENTS AND METHODS Plots of cumulatively received chemotherapy against time were used to evaluate drug delivery by regimen, major prognostic factors, and response status. RESULTS Individual CAP patients show a narrow range of received DI, with the median similar to protocol. Drug delivery analysis exposed a wide range of received DI for both drugs in the more intensive VP regimen, and the median received DI was below protocol. The median received DI for cisplatin was still higher for VP than CAP, but only during the first 8 weeks of protocol treatment (20 v 10 mg/m2/wk); thereafter, the ongoing received cisplatin DI was the same (10 mg/m2/wk). The median received DI for cisplatin in each regimen was not influenced by stage, performance status, prior weight loss, sex, or response status. VP-treated patients received a higher total dose of cisplatin than CAP patients (median, 255 mg/m2 v 112.5 mg/m2; P < .0001). Median cisplatin total dose was similar for patients with a chemotherapy response or stable disease and threefold greater than for patients with progressive disease for both regimens. Although patients with chemotherapy response and stable disease had similar survival outcomes for both CAP and VP, the VP regimen had a higher proportion of patients without progressive disease (P = .004), which resulted in an overall survival advantage (P = .01). CONCLUSION The major prognostic factors for advanced NSCLC do not exert their influence on outcome by affecting deliverable chemotherapy DI. Regimen and treatment response determined total dose. Because stable disease patients usually outnumber responding patients in advanced NSCLC trials, controlled studies should be performed that allow assessment of the impact of total received dose on outcome according to response status." @default.
• W2253177453 created "2016-06-24" @default.
• W2253177453 creator A5017551211 @default.
• W2253177453 creator A5019770927 @default.
• W2253177453 creator A5032748645 @default.
• W2253177453 creator A5040731269 @default.
• W2253177453 creator A5076175869 @default.
• W2253177453 date "1994-11-01" @default.
• W2253177453 modified "2023-09-23" @default.
• W2253177453 title "Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer." @default.
• W2253177453 cites W1755983531 @default.
• W2253177453 cites W1803099259 @default.
• W2253177453 cites W1899541887 @default.
• W2253177453 cites W1919092210 @default.
• W2253177453 cites W1996426542 @default.
• W2253177453 cites W2045085743 @default.
• W2253177453 cites W2059563719 @default.
• W2253177453 cites W2083622248 @default.
• W2253177453 cites W2083702415 @default.
• W2253177453 cites W2086993950 @default.
• W2253177453 cites W2090574148 @default.
• W2253177453 cites W2189078389 @default.
• W2253177453 cites W2242162861 @default.
• W2253177453 cites W2242204182 @default.
• W2253177453 cites W2256942795 @default.
• W2253177453 cites W2327103565 @default.
• W2253177453 cites W2397436995 @default.
• W2253177453 cites W2401585999 @default.
• W2253177453 cites W2408315716 @default.
• W2253177453 cites W2418587780 @default.
• W2253177453 cites W2898804643 @default.
• W2253177453 doi "https://doi.org/10.1200/jco.1994.12.11.2333" @default.
• W2253177453 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7964949" @default.
• W2253177453 hasPublicationYear "1994" @default.
• W2253177453 type Work @default.
• W2253177453 sameAs 2253177453 @default.
• W2253177453 citedByCount "14" @default.
• W2253177453 crossrefType "journal-article" @default.
• W2253177453 hasAuthorship W2253177453A5017551211 @default.
• W2253177453 hasAuthorship W2253177453A5019770927 @default.
• W2253177453 hasAuthorship W2253177453A5032748645 @default.
• W2253177453 hasAuthorship W2253177453A5040731269 @default.
• W2253177453 hasAuthorship W2253177453A5076175869 @default.
• W2253177453 hasConcept C126322002 @default.
• W2253177453 hasConcept C141071460 @default.
• W2253177453 hasConcept C143998085 @default.
• W2253177453 hasConcept C197934379 @default.
• W2253177453 hasConcept C2776256026 @default.
• W2253177453 hasConcept C2776694085 @default.
• W2253177453 hasConcept C2776755627 @default.
• W2253177453 hasConcept C2778239845 @default.
• W2253177453 hasConcept C2778336483 @default.
• W2253177453 hasConcept C2778375690 @default.
• W2253177453 hasConcept C2779321808 @default.
• W2253177453 hasConcept C2779429289 @default.
• W2253177453 hasConcept C2781413609 @default.
• W2253177453 hasConcept C2908647359 @default.
• W2253177453 hasConcept C71924100 @default.
• W2253177453 hasConcept C99454951 @default.
• W2253177453 hasConceptScore W2253177453C126322002 @default.
• W2253177453 hasConceptScore W2253177453C141071460 @default.
• W2253177453 hasConceptScore W2253177453C143998085 @default.
• W2253177453 hasConceptScore W2253177453C197934379 @default.
• W2253177453 hasConceptScore W2253177453C2776256026 @default.
• W2253177453 hasConceptScore W2253177453C2776694085 @default.
• W2253177453 hasConceptScore W2253177453C2776755627 @default.
• W2253177453 hasConceptScore W2253177453C2778239845 @default.
• W2253177453 hasConceptScore W2253177453C2778336483 @default.
• W2253177453 hasConceptScore W2253177453C2778375690 @default.
• W2253177453 hasConceptScore W2253177453C2779321808 @default.
• W2253177453 hasConceptScore W2253177453C2779429289 @default.
• W2253177453 hasConceptScore W2253177453C2781413609 @default.
• W2253177453 hasConceptScore W2253177453C2908647359 @default.
• W2253177453 hasConceptScore W2253177453C71924100 @default.
• W2253177453 hasConceptScore W2253177453C99454951 @default.
• W2253177453 hasIssue "11" @default.
• W2253177453 hasLocation W22531774531 @default.
• W2253177453 hasLocation W22531774532 @default.
• W2253177453 hasOpenAccess W2253177453 @default.
• W2253177453 hasPrimaryLocation W22531774531 @default.
• W2253177453 hasRelatedWork W2062239485 @default.
• W2253177453 hasRelatedWork W2091720821 @default.
• W2253177453 hasRelatedWork W2121694206 @default.
• W2253177453 hasRelatedWork W2358269044 @default.
• W2253177453 hasRelatedWork W2388730008 @default.
• W2253177453 hasRelatedWork W2403331838 @default.
• W2253177453 hasRelatedWork W2522899364 @default.
• W2253177453 hasRelatedWork W363598932 @default.
• W2253177453 hasRelatedWork W4234586607 @default.
• W2253177453 hasRelatedWork W4243215019 @default.
• W2253177453 hasVolume "12" @default.
• W2253177453 isParatext "false" @default.
• W2253177453 isRetracted "false" @default.
• W2253177453 magId "2253177453" @default.
• W2253177453 workType "article" @default.